Received Jul 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 42Y93 | — |
patient received a dose of Kinrix instead of Pediarix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 2-year-old female patient who received DTPa-IPV (Kinrix) (batch number 42Y93, expiry date 05-JUN-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. Previously administered products included Pediarix (Patient has 2 previous doses of Pediarix) and Pediarix (Patient has 2 previous doses of Pediarix). On an unknown date, the patient received Kinrix and Pediarix. On an unknown date, an unknown time after receiving Kinrix and Pediarix, the patient experienced wrong vaccine administered (Verbatim: patient received a dose of Kinrix instead of Pediarix). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 30-JUN-2025 Other reported that they administered a dose of Kinrix to a female patient who was 2 years old instead of Pediarix, which led to wrong vaccine administered. Do they need to revaccinate? What are the next steps? Any safety information available? Patient had 2 previous doses of Pediarix.